Anavex Life Sciences Corp (AVXL)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
AVXL Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
AVXL Quarterly Deferred Revenue ($0.00 → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
AVXL deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 805,000 | |
| 805,000 | |
| 805,000 | |
| 805,000 | |
| 829,000 | |
| 829,000 | |
| 842,000 | |
| 917,000 | |
| 917,000 | |
| 917,000 | |
| 917,000 | |
| 916,763 | |
| 916,763 | |
| 916,763 | |
| 444,000 | |
| 443,831 | |
| 443,831 | |
| 443,831 | |
| 443,831 | |
| 443,831 | |
| 487,111 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 19,073 | |
| 86,205 | |
| 31,481 | |
| 70,532 | |
| 27,124 | |
| 5,445 | |
| 32,559 | |
| 71,614 | |
| -1,207,829 | |
| -1,397,923 | |
| -1,284,108 | |
| -1,220,852 | |
| -1,671,303 | |
| -1,666,409 | |
| -1,591,926 | |
| -1,711,350 | |
| -2,766,115 | |
| -2,641 | |
| -2,602 | |
| -2,462 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,293,589 | |
| -582,937 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -3,272,839 | |
| 0 | |
| 0 | |
| 0 | |
| -1,107,709 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |